Locked-in syndrome (LIS) is a complex medical condition presenting with quadriplegia, bulbar palsy, and whole-body sensory loss due to damage in the brain stem, most commonly the anterior pons. Cognition, vertical eye movement, blinking, and hearing are classically preserved in patients suffering from the condition. The diagnosis of the locked-in syndrome is often challenging due to its similarity with conditions such as akinetic mutism and coma. It may take weeks to diagnose, and family members at the bedside are usually the first to notice the decreased motor functions of the patient.
Locked-in syndrome has three main types. The classical form is defined by total immobility, with preservation of the ability to perform vertical eye movements, blink, and maintain a normal level of consciousness. The incomplete form is defined as the classical form with small additional motor functions. The total immobility form is defined as a complete body paralysis, and loss of eye movement with the preservation of cortical function examined via EEG. In the classical and incomplete forms, consciousness is often evaluated by blink-response or eye movement-response to questions. An EEG may be used in patients in the complete form to assess brain activity, sleep-wake cycles, and attention.
In the acute setting, CT or MRI of the brain helps characterize the causative agent to establish a treatment earlier. Physical examinations analyzing motor function, sensation, and reflexes are often reassessed to rule out other potential conditions and estimate the rate of recovery in patients. Due to the rare nature of this condition, recovery and management have been a topic of debate. Still, an increasing amount of literature has demonstrated efficacy in traditional supportive management and rehabilitation.
Locked-in syndrome is caused by any lesion affecting the ventral pons, and midbrain; this includes vascular lesions, masses, infections, traumas, and demyelinating disorders.
The most common cause is a vascular complication in the form of a hemorrhagic or ischemic stroke. A study by Patterson and Brabois (1986) reviewed a total of 139 cases of locked-in syndrome between 1959-1983 and divided cases into vascular and nonvascular causes. In a total of 139 cases,105 cases had insults caused by vascular etiology, while 34 cases were from nonvascular events. A history of hypertension was present in 43 cases, all of whom were in the vascular group—additional medical history includes 8 cases with atherosclerotic disease and 5 cases with atrial fibrillation. A survey conducted by the Association of Locked-in Syndrome of France (ALIS), which obtained information from 44 people diagnosed with LIS, had similar results with a total of 86.4% of participants listing stroke as the causative agent of their condition.
Traumatic brain injury has been reported as the second-largest cause of LIS after vascular etiologies. Posttraumatic LIS has been reported from either blunt or penetrating trauma leading to either a tear or thrombotic occlusion of the vertebrobasilar artery blood supply. Only one case reported a post-traumatic LIS with no direct physical damage to the brainstem. In this case, the patient had developed a post-traumatic ventral pontomedullary contusion after the incident resulting in a pressure impingement of the brainstem.
Masses affecting the ventral pons or caudal ventral midbrain can precipitate the locked-in syndrome. Fibrillary astrocytoma, pontine reticulum cell sarcoma, metastasis from an adenocarcinoma of the lung, and metastasis from a malignant melanoma have previously been reported in the literature as precipitating causes.
Infection is a rare cause of LIS with a limited amount of cases published in the literature. One case reports a LIS stemming from a Pseudomonas predominant pontine abscess. Two reports of meningitis have been reported. One of which involved the adjacent spread from a brainstem abscess, the other involving severe meningitis causing an increase in intracranial pressure leading to transmitted pressure to brainstem structures.
LIS can be caused by metabolic demyelination, most notably from central pontine myelinolysis, which is a result of the rapid correction of hyponatremia. Although very rare, LIS has been reported in severe cases of demyelinating diseases such as multiple sclerosis (MS), Guillain-Barre syndrome, and amyotrophic lateral sclerosis (ALS).
The mean age of onset for all cases of the locked-in syndrome has generally ranged from 30-50 years. The condition is slightly male predominant. In the ALIS study, amongst men and women who received LIS from vascular and nonvascular agents, both groups were affected equally: 51.2% of men diagnosed vs. 48.1 % of women diagnosed. The age of onset in this study was between 22-77 years of age, with a mean age of 46.79 years. Other retrospective studies had similar results with, on average, more males being affected and mean ages ranging from 33-45 years for both vascular and nonvascular causes. Many patients with LIS from a vascular etiology had comorbid conditions such as hypertension, atherosclerosis of major arteries, and diabetes.
Locked-in syndrome is precipitated by any lesion affecting the ventral pons or the caudal ventral midbrain while the integrity of the cerebrum remains intact.
The nucleus of the 3rd cranial nerve lies ventromedial in the midbrain near the cerebral aqueduct. Tracts project anteriorly from this nucleus to innervate muscles of the eye. Pupillary reflex mediated by parasympathetic nerves that travel on the 3rd cranial nerve distally may be variably conserved in episodes of ischemia. Lesions of the ventromedial midbrain will affect the nucleus of this nerve, which may cause complete locked-in syndrome.
Cranial nerves 4 and cranial nerve 6, which control downward eye movement via the superior oblique muscles and the abduction of the eyes via the lateral rectus muscles respectively, may be affected in a ventral pons lesion.
The corticobulbar tracts passing through the midbrain and pons contain upper motor neurons for cranial nerves 5, 7, 9, 10, 11, and 12. The pontine respiratory group located in the pons tegmentum could be affected in large lesions leading to signs of apnea and respiratory distress. The reticular activating system, which lies dorsally, is responsible for wakefulness and is not damaged by such ventral lesions.
The corticospinal and spinothalamic tracts mediate limb and truncal motor and sensory functions. Both of these tracts travel through the crus cerebri of the midbrain and ventral pons and will subsequently be affected by a ventral brainstem lesion.
The ventral pons is supplied by the basilar artery, which is fed by two vertebral arteries. Any abnormalities of these arteries can present with signs of locked-in syndrome. The presentation may vary on a case to case basis due to the nature of the causative agent, which makes a correct initial diagnosis difficult.
Locked-in syndrome may have a variety of presenting symptoms. The three-tier categorization of the forms of LIS (classical, incomplete, and total immobility) made by Bauer (1979) presents a basic framework in elucidating patient presentation given the severity of the condition. Many common symptoms of the locked-in syndrome are a function of the disruption of the neuronal tracts that pass through the ventral brainstem:
Providers should be steadfast in obtaining interviews from surrounding family members. It is imperative to evaluate the symptom onset and whether there have been fluctuations or progress of symptoms over time. Acute symptom onset should suggest a rapidly progressing etiology, such as in the case of strokes, trauma, or metabolic demyelination. Subacute symptom onset will be consistent with infectious etiologies, pontine contusions, or Guillain-Barre syndrome if the loss of motor function follows an ascending pattern with concurrent functional respiratory failure. Chronic recurrent symptoms, especially in those with relapsing sensorineural deficits, will be consistent with an autoimmune demyelinating condition. Prodromal and current symptoms consistent with an infectious etiology such as fevers, chills, malaise, headache, neck stiffness, and photophobia should be evaluated in cases of suspected meningitis or abscess. History of violent accidents such as motor vehicle accidents should be probed to be able to rule in or rule out trauma and promptly stabilize the patient and mitigate ongoing damage.
Patients with the locked-in syndrome may either have a causative agent that primarily affects the brainstem or diffusely affects the CNS.
The physical and neurologic examination of cranial nerves can show impairment of the horizontal eye movement and sparing of the vertical eye movements. There is also the involvement of cranial nerves 5, 7, 9, 10, 11, and 12, which presents as a bilateral sensory deficit to the face, bilateral peripheral facial palsy, absent gag reflex, weak tongue movement, and neck weakness. Hearing is often preserved in LIS; however, patients often do not have the means to communicate due to the paralysis. In this case, hearing and the integrity of the cranial nerve 8 may be tested by a patient's response to verbal communication with vertical eye motions in the form of "yes and no" responses. Both pupillary reflex and the vestibulocochlear reflex may be preserved in LIS.
Testing of motor strength, sensory deficits, and reflexes should all be done to localize the site of the lesion as well as to monitor for progress or improvement. Locked-in syndrome presents with bilateral weakness and sensory deficits that may be variable. Complete quadriplegia is reported in almost all patients, while proprioception, light touch, temperature, pain sensation is greatly decreased if not completely diminished. Examination of the reflexes can point to an upper motor neuron involvement like in hyperreflexia or of lower motor neuron involvement in hyporeflexia or areflexia. A positive Babinski reflex indicates corticospinal damage, usually located in ventral structures of the brainstem.
It is important to note that patients suffering from a brainstem stroke or large brainstem lesions may initially fall into a comatose state. From here, it may take weeks before the patient transitions into a locked-in state, or a member of the practicing team successfully identifies intact cognition and sudden movement. According to León-Carrión et al. (2002), the average time to diagnosis was two months after the onset of the inciting event. The diagnosis is often confused with other similar conditions such as akinetic mutism and persistent vegetative states.
The early recognition of the symptoms of LIS may mitigate the considerable lag time between injury onset and time of formal diagnosis. Serial monitoring of patients should be standard, assessment of alertness by eye movement, spontaneous or voluntary limb movements, withdrawal to noxious stimuli, and reflexes. Patients who are emerging from a comatose state require special attention, daily assessment of visual tracking, eye movements, and eye blinking in response to the caregiver is especially important. León-Carrión et al. (2002) demonstrated that in over half of the cases examined in his review, the first individual to indicate that the patient could generate spontaneous voluntary movement was a family member. Providers should, therefore, attempt to retrieve any bedside information from family to make sure minor improvements are not missed.
Brain imaging by CT or MRI is the most valuable modality used in the diagnosis of locked-in syndrome. The addition of CT or MR angiography can show vascular lesions causing the syndrome in cases of stroke or arterial dissection. The addition of contrast medium can delineate masses like tumors or abscesses and even active demyelinating lesions.
The cerebrospinal fluid examination (CSF) is usually necessary if no mass or vascular lesion is present on imaging. Results of the CSF analysis may reveal an infectious or autoimmune cause of the symptoms. The CSF should be sent for differential cell count, protein, glucose, staining, cultures, and CSF protein electrophoresis (IgG oligoclonal bands for MS).
Diagnosis of other demyelinating neuropathies such as ALS or GBS may be made via electromyography and nerve conduction studies, in conjunction with the physical examination.
Additionally, an EEG may be used in patients to evaluate brain activity, sleep-wake cycles, and attention. Language comprehension and orientation may be assessed through infrared eye movement sensors in cases of classical and complete LIS or computer modulated voice prosthetics in cases of incomplete LIS.
A metabolic panel should be ordered to evaluate any aberration in the sodium level, which may indicate a potential pontine myelinolysis. A history of rapid sodium correction may point to the cause of demyelination.
Hyponatremia, hypophosphatemia, and hypomagnesemia may cause comas similar to a locked-in state, so such electrolytes should be closely examined. Glucose should be monitored to rule out a hypoglycemic coma. A complete blood count should be done to rule out sepsis as a cause of coma.
The removal or reversal of the causative agent primarily treats locked-in syndrome. Initially, acute management of locked-in syndrome should be focused on securing a patent airway, maintaining adequate oxygen saturation levels, and ensuring the patient is stable from a cardiac standpoint using heart rate, blood pressure, and occasionally orthostatic hypotension as predictive markers.
Care is then addressed at treating the precipitating agent. In the event of an ischemic or hemorrhagic stroke, the stroke protocol should be swiftly employed. Prompt thrombolytic therapy has been shown in one case to expedite the recovery process to nearly full recovery in ischemia related to LIS.
Treatments for demyelinating diseases are variable. The treatment of LIS from central pontine myelinolysis is focussed on supportive measures: gradual correction of sodium abnormalities and close monitoring of respiratory status is imperative.  Inflammatory neuropathies may be treated in a somewhat similar fashion. Guillain-Barre syndrome may be treated with IVIG, plasmapheresis, and monitored airway ventilation. Exacerbations of multiple sclerosis may be treated with high dose glucocorticoids acutely with relapses treated with disease-modifying agents and humanized monoclonal antibodies. ALS may be treated with supportive measures in conjunction with long term agents riluzole or edaravone to prolong survival.
Subacute and chronic therapy aims at improving the patient's motor functionality months after the onset of the insult. Management at this stage should be based primarily on physical, respiratory, and speech therapy. Chest physiotherapy, breathing exercises, positional changes may also be incorporated to maintain adequate cardiovascular and respiratory function. Assisted technology such as infrared eye movement sensors or computer modulated voice prosthetics may be used for speech therapy to improve communication gradually. Communication books outlining thoughts and activities can be beneficial in tracking cognitive recovery as well.
The diagnosis of locked-in syndrome can often be difficult since the condition shares many features with other mute conditions.
Medical states such as coma, persistent vegetative state, akinetic mutism, and catatonic states are the main confounding conditions.
Radiography and early physical exams should be used to localize the structures damaged. Loss of facial expressions, dysphagia, lack of neck movement and tone, and lack of the gag reflex indicates a corticobulbar lesion at the ventral structures of the midbrain or pons.
Surdyke et al. (2017) published a case in which a small algorithmic model was used to rule out other related causative agents. First, consciousness, alertness, and ability to communicate were assessed. If this was present, the assessment of cervical cord injury was done via observation of respiration, and assessment of supraspinal muscles. Lastly, an evaluation to rule out akinetic mutism was done. If all three are negative, the suspicion for LIS is high.
Additionally, in a condition as complex as LIS, care should be taken to obtain a thorough history to exclude a potential intoxication. A detailed drug history should examine depressive drugs, anesthetics, and poisons that may temporarily mimic a locked-in state. Curare, a reversible nicotinic acetylcholine receptor inhibitor, has been described as a drug that may cause complete quadriplegia and respiratory failure mimicking a variable form of locked-in syndrome. Prompt stabilization of the patient and a thorough history will help exclude less common causes of the locked-in syndrome to aid in quicker management.
Mortality and recovery are highly variable depending on the underlying cause of the locked-in syndrome. Locked-in syndrome generally has a high mortality rate in the acute setting. Retrospective studies and analysis models have estimated the 5-year and 10-year mortality rate of 84% and 31%, respectively. The review by Patterson and Grabios on 139 cases of LIS revealed an overall mortality rate of 60%. Mortality rates for vascular causes of the condition were 67% (70 of 105 patients) versus 41% (14 of 34 patients) for nonvascular cases. Many survivors in this study remained in a state where motor functionality had minimally progressed.
Patterson and Grabois categorized patients into five different groups based on recovery a few months after the onset of their condition:
The study demonstrated that more nonvascular cases had moderate to full recovery. A total of 18 out of the 34 patients who suffered from a nonvascular exhibited some return of motor function. Additionally, 12 of the 18 recovery cases experienced a full recovery during the first six months.
In contrast, only 29 of the 105 total vascular patients had developed some form of recovery after the onset of their condition. Of the patients who survived after the initial four months, 13 of 16 showed evidence of moderate to full functional recovery, with only 2 cases experiencing a full recovery.
Locked-in syndrome has debilitating complications after initial stabilization has been achieved. Aside from the high mortality rate, numerous cases report complete or partial paralysis among survivors. One study reports 18 of the 29 cases followed in the review survived, with eleven of the survivors residing in their homes, the others living permanent hospital residents, and in nursing homes. Even for the patients who were sent home, the majority required assistance in activities of daily living. A minority was able to live independently and even take part-time jobs. The same report demonstrated that communication never improved to a high functional level, with many survivors requiring a communication device or computer.
Due to the extended hospital stay of many patients suffering from LIS and frequent inpatient procedures, many patients get multiple nosocomial infections. Long term intubation has led to the development of pneumonia, and catheterization has lead to the development of urinary tract infections in patients with LIS. Deep vein thrombosis and bedsores are common complications due to the patient's bed-bound state. In one report, only 42% of recovered patients experienced a complete improvement in swallowing, and 50% of recovered patients had difficulty with normal breathing. Both bladder and bowel incontinence have been reported as well in many of these patients in the long term.
Locked-in syndrome may be ambiguous in presentation, leading to a difficult and often missed diagnosis. It is first and foremost to stabilize the patient's airway, breathing, and circulation in the acute setting. Examining consciousness and alertness should be done in conjunction with a physical exam to help localize and watch out for the progression of the symptoms. Imaging studies should be obtained to further characterize the causative agent. An EEG can be ordered to confirm consciousness. Serial neurological exams, specifically examining withdrawal from noxious stimuli, bodily reflexes, and spontaneous eye reflexes should be done to assess for a decline or improvement of the patient's symptoms. This is especially true in those emerging from a comatose state. It is important for the medical team to localize the lesion and to examine if the problem truly stems from a disruption of normal brainstem integrity.
Post-stabilization rehabilitation therapy in the form of speech and physical therapy are recommended in the subacute and chronic stages of recovery. Such programs allow patients to be able to work toward the goal of gradual recovery and independent function to complete activities of daily living. Regaining some motor function in the first few months after the insult has been shown to increase functionality, outcomes, and quality of life. In a condition as complex as locked-in syndrome, the medical team should be swift in trying to assess all aspects of a patient's functionality over time in order to make an earlier diagnosis and begin rehabilitation programs to improve the quality and duration of a patient's life.
The long term outcomes and complications should be discussed with the family and those providing support after discharge. A coordinated effort from the family and medical team to schedule and follow up with speech and physical therapy is important for patients who are severely disabled to gradually recover to an acceptable semi-dependent state. A discussion about realistic goals of therapy should not be missed. Patients may also benefit from assisted technology such as infrared eye movement sensors or computer modulated voice prosthetics to properly track outcomes and progression while in therapy.
Overall, coordination between providers, nurses, and the therapists responsible for patient care can largely improve outcomes in these patients and reduce the delay to the formal diagnosis. Such a patient-centered approach allows for an improvement in patient safety during and after the patient's hospital stay while helping to improve recovery.
|||Laureys S,Pellas F,Van Eeckhout P,Ghorbel S,Schnakers C,Perrin F,Berré J,Faymonville ME,Pantke KH,Damas F,Lamy M,Moonen G,Goldman S, The locked-in syndrome : what is it like to be conscious but paralyzed and voiceless? Progress in brain research. 2005; [PubMed PMID: 16186044]|
|||Bauer G,Gerstenbrand F,Rumpl E, Varieties of the locked-in syndrome. Journal of neurology. 1979 Aug; [PubMed PMID: 92545]|
|||Lesenfants D,Habbal D,Chatelle C,Soddu A,Laureys S,Noirhomme Q, Toward an Attention-Based Diagnostic Tool for Patients With Locked-in Syndrome. Clinical EEG and neuroscience. 2018 Mar; [PubMed PMID: 27821482]|
|||Patterson JR,Grabois M, Locked-in syndrome: a review of 139 cases. Stroke. 1986 Jul-Aug; [PubMed PMID: 3738962]|
|||León-Carrión J,van Eeckhout P,Domínguez-Morales Mdel R,Pérez-Santamaría FJ, The locked-in syndrome: a syndrome looking for a therapy. Brain injury. 2002 Jul; [PubMed PMID: 12119076]|
|||Cabezudo JM,Olabe J,Lopez-Anguera A,Bacci F, Recovery from locked-in syndrome after posttraumatic bilateral distal vertebral artery occlusion. Surgical neurology. 1986 Feb [PubMed PMID: 3941989]|
|||Odabaşi Z,Kütükçü Y,Gökçil Z,Vural O,Yardim M, Traumatic basilar artery dissection causing locked-in syndrome. Minimally invasive neurosurgery : MIN. 1998 Mar [PubMed PMID: 9565966]|
|||Schoeggl A,Reddy M,Bavinzski G, A lateral mass fracture of C1 associated with left vertebral artery and mid-basilar artery occlusion. Journal of neurotrauma. 2001 Jul [PubMed PMID: 11497099]|
|||Fitzgerald LF,Simpson RK,Trask T, Locked-in syndrome resulting from cervical spine gunshot wound. The Journal of trauma. 1997 Jan [PubMed PMID: 9003276]|
|||Ahn ES,Aarabi B, Posttraumatic locked-in syndrome from a pontomedullary contusion: case report. The Journal of trauma. 2007 Aug [PubMed PMID: 17514062]|
|||Inci S,Ozgen T, Locked-in syndrome due to metastatic pontomedullary tumor--case report. Neurologia medico-chirurgica. 2003 Oct [PubMed PMID: 14620202]|
|||Murphy MJ,Brenton DW,Aschenbrener CA,Van Gilder JC, Locked-in syndrome caused by a solitary pontine abscess. Journal of neurology, neurosurgery, and psychiatry. 1979 Nov [PubMed PMID: 501372]|
|||Mathais Q,Esnault P,Montcriol A,Gazzola S,Prunet B,Meaudre E, Locked-in syndrome following meningitis with brainstem abscess. Revue neurologique. 2019 Jan - Feb [PubMed PMID: 30274815]|
|||Habre W,Caflisch M,Chaves-Vischer V,Delavelle J,Haenggeli CA, Locked-in syndrome in an adolescent patient with pneumococcal meningitis. Neuropediatrics. 1996 Dec [PubMed PMID: 9050051]|
|||Heckmann JG,Dinkel HP, Recovery of locked-in syndrome in central pontine myelinolysis. The American journal of case reports. 2013 [PubMed PMID: 23826473]|
|||Forti A,Ambrosetto G,Amore M,De Maria R,Michelucci R,Omicini E,Rizzuto N,Fenzi F,Tassinari CA, Locked-in syndrome in multiple sclerosis with sparing of the ventral portion of the pons. Annals of neurology. 1982 Oct [PubMed PMID: 7149663]|
|||Keme-Ebi IK,Asindi AA, Locked-in Syndrome in a Nigerian male with Multiple Sclerosis: a case report and literature review. The Pan African medical journal. 2008 Oct 30 [PubMed PMID: 21532893]|
|||Medici C,Gonzalez G,Cerisola A,Scavone C, Locked-in syndrome in three children with Guillain-Barré syndrome. Pediatric neurology. 2011 Aug [PubMed PMID: 21763955]|
|||Vansteensel MJ,Pels EGM,Bleichner MG,Branco MP,Denison T,Freudenburg ZV,Gosselaar P,Leinders S,Ottens TH,Van Den Boom MA,Van Rijen PC,Aarnoutse EJ,Ramsey NF, Fully Implanted Brain-Computer Interface in a Locked-In Patient with ALS. The New England journal of medicine. 2016 Nov 24 [PubMed PMID: 27959736]|
|||Doble JE,Haig AJ,Anderson C,Katz R, Impairment, activity, participation, life satisfaction, and survival in persons with locked-in syndrome for over a decade: follow-up on a previously reported cohort. The Journal of head trauma rehabilitation. 2003 Sep-Oct; [PubMed PMID: 12973273]|
|||Casanova E,Lazzari RE,Lotta S,Mazzucchi A, Locked-in syndrome: improvement in the prognosis after an early intensive multidisciplinary rehabilitation. Archives of physical medicine and rehabilitation. 2003 Jun; [PubMed PMID: 12808539]|
|||Richard I,Péreon Y,Guiheneu P,Nogues B,Perrouin-Verbe B,Mathe JF, Persistence of distal motor control in the locked in syndrome. Review of 11 patients. Paraplegia. 1995 Nov; [PubMed PMID: 8584298]|
|||Stoll J,Chatelle C,Carter O,Koch C,Laureys S,Einhäuser W, Pupil responses allow communication in locked-in syndrome patients. Current biology : CB. 2013 Aug 5; [PubMed PMID: 23928079]|
|||Surdyke L,Fernandez J,Foster H,Spigel P, Differential Diagnosis and Management of Incomplete Locked-In Syndrome after Traumatic Brain Injury. Case reports in neurological medicine. 2017; [PubMed PMID: 28695029]|
|||Smith E,Delargy M, Locked-in syndrome. BMJ (Clinical research ed.). 2005 Feb 19; [PubMed PMID: 15718541]|
|||Ömerhoca S,Akkaş SY,İçen NK, Multiple Sclerosis: Diagnosis and Differential Diagnosis. Noro psikiyatri arsivi. 2018 [PubMed PMID: 30692847]|
|||Tao QQ,Wu ZY, Amyotrophic Lateral Sclerosis: Precise Diagnosis and Individualized Treatment. Chinese medical journal. 2017 Oct 5 [PubMed PMID: 28937029]|
|||Lee JW, Fluid and electrolyte disturbances in critically ill patients. Electrolyte & blood pressure : E & BP. 2010 Dec [PubMed PMID: 21468200]|
|||Cryer PE, Hypoglycemia, functional brain failure, and brain death. The Journal of clinical investigation. 2007 Apr [PubMed PMID: 17404614]|
|||Johnson TM,Romero CS,Smith AT, Locked-in syndrome responding to thrombolytic therapy. The American journal of emergency medicine. 2018 Oct; [PubMed PMID: 29983216]|
|||Lampl C,Yazdi K, Central pontine myelinolysis. European neurology. 2002 [PubMed PMID: 11803185]|
|||Leonhard SE,Mandarakas MR,Gondim FAA,Bateman K,Ferreira MLB,Cornblath DR,van Doorn PA,Dourado ME,Hughes RAC,Islam B,Kusunoki S,Pardo CA,Reisin R,Sejvar JJ,Shahrizaila N,Soares C,Umapathi T,Wang Y,Yiu EM,Willison HJ,Jacobs BC, Diagnosis and management of Guillain-Barré syndrome in ten steps. Nature reviews. Neurology. 2019 Nov [PubMed PMID: 31541214]|
|||Dargahi N,Katsara M,Tselios T,Androutsou ME,de Courten M,Matsoukas J,Apostolopoulos V, Multiple Sclerosis: Immunopathology and Treatment Update. Brain sciences. 2017 Jul 7 [PubMed PMID: 28686222]|
|||Schultz J, Disease-modifying treatment of amyotrophic lateral sclerosis. The American journal of managed care. 2018 Aug [PubMed PMID: 30207671]|
|||Ambrosino N,Venturelli E,Vagheggini G,Clini E, Rehabilitation, weaning and physical therapy strategies in chronic critically ill patients. The European respiratory journal. 2012 Feb; [PubMed PMID: 22135278]|
|||Laureys S,Owen AM,Schiff ND, Brain function in coma, vegetative state, and related disorders. The Lancet. Neurology. 2004 Sep [PubMed PMID: 15324722]|
|||Medical aspects of the persistent vegetative state (1). The New England journal of medicine. 1994 May 26 [PubMed PMID: 7818633]|
|||Jennett B,Bond M, Assessment of outcome after severe brain damage. Lancet (London, England). 1975 Mar 1 [PubMed PMID: 46957]|
|||Nagaratnam N,Nagaratnam K,Ng K,Diu P, Akinetic mutism following stroke. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2004 Jan [PubMed PMID: 14642361]|
|||Carl J,Schwarzer M,Klingelhoefer D,Ohlendorf D,Groneberg DA, Curare--a curative poison: a scientometric analysis. PloS one. 2014; [PubMed PMID: 25409503]|
|||Shavelle RM,Strauss DJ,Katz RT, Survival of persons with locked-in syndrome. Archives of physical medicine and rehabilitation. 2008 May; [PubMed PMID: 18452754]|
|||Katz RT,Haig AJ,Clark BB,DiPaola RJ, Long-term survival, prognosis, and life-care planning for 29 patients with chronic locked-in syndrome. Archives of physical medicine and rehabilitation. 1992 May; [PubMed PMID: 1580764]|
|||Haig AJ,Katz RT,Sahgal V, Mortality and complications of the locked-in syndrome. Archives of physical medicine and rehabilitation. 1987 Jan [PubMed PMID: 2432852]|